Diagnostic Center | October 16, 2021
Metropolis Healthcare board approves acquisition of Hitech for Rs 636 crore
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
Emkay Research expects Q2FY22 to be a normalised quarter for pharma companies that it tracks. A summary of the report
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
Since its inception, the company has either acquired or taken a majority stake in five companies
In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks
Subscribe To Our Newsletter & Stay Updated
